Sharps Technology (NASDAQ:STSS) Posts Earnings Results

Sharps Technology (NASDAQ:STSS) issued its earnings results on Thursday. The company reported ($2.87) EPS for the quarter, Zacks reports.

Sharps Technology Stock Performance

NASDAQ:STSS opened at $0.15 on Friday. The firm has a market capitalization of $839,544.60, a price-to-earnings ratio of -0.02 and a beta of 1.47. Sharps Technology has a 12 month low of $0.13 and a 12 month high of $18.15. The company has a 50-day moving average price of $0.52.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.